SEC Form 4 · accession 0001209191-18-058931
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Tepper
Officer — President and CSO
Period of report
Nov 14, 2018
Accepted (ET)
Nov 16, 2018 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 14, 2018 | M | 10,000 | $1.00 | A | 2,110,400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stock | $1.00 | Nov 14, 2018 | M | 10,000 | D | Apr 11, 2015 | Apr 11, 2024 | Common Stock | 10,000 | 261,600 | D |